Conversion of immunosuppressive therapy to sirolimus (Rapamune) monotherapy for complications of calcineurin inhibitors in patients undergoing orthotopic liver transplantation. [Conversione della terapia immunosoppressiva a Sirolimus (Rapamune) monoterapia per complicanze da inibitori della calcineurina, in pazienti sottoposti a trapianto ortotopico di fegato.]

Trial Profile

Conversion of immunosuppressive therapy to sirolimus (Rapamune) monotherapy for complications of calcineurin inhibitors in patients undergoing orthotopic liver transplantation. [Conversione della terapia immunosoppressiva a Sirolimus (Rapamune) monoterapia per complicanze da inibitori della calcineurina, in pazienti sottoposti a trapianto ortotopico di fegato.]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Jan 2013

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Liver transplant rejection
  • Focus Adverse reactions
  • Acronyms SIROLIMUS-MONO
  • Most Recent Events

    • 22 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top